Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Renal Cell Carcinoma”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)Looking for participantsNCT06004336
What this trial is testing

Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs)

Who this might be right for
Oligometastatic Renal Cell Carcinoma
M.D. Anderson Cancer Center 144
Not applicableStudy completedNCT02170181
What this trial is testing

Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation

Who this might be right for
Cancer Patients Receiving Stereotactic Body RTX
University of Texas Southwestern Medical Center 149
Testing effectiveness (Phase 2)Temporarily pausedNCT03575611
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
M.D. Anderson Cancer Center 123
Testing effectiveness (Phase 2)UnknownNCT05578664
What this trial is testing

Efficacy of PErioperative PEmbrolizumab Treatment in Patients With Resectable Metastases From Kidney Cancer

Who this might be right for
Oligometastatic Renal Cell Carcinoma
Consorzio Oncotech 81
Not applicableEnded earlyNCT02542202
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Metastatic Renal Cell CancerRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
University of Chicago 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05863351
What this trial is testing

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

Who this might be right for
Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
ECOG-ACRIN Cancer Research Group 472
Testing effectiveness (Phase 2)Ended earlyNCT05846646
What this trial is testing

Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCC

Who this might be right for
Oligometastatic Disease
ImmuneSensor Therapeutics Inc. 6
Testing effectiveness (Phase 2)Looking for participantsNCT07744932
What this trial is testing

SABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma

Who this might be right for
Oligometastatic Clear Cell Renal Cell Carcinoma
Hebei Medical University Fourth Hospital 48
Large-scale testing (Phase 3)Looking for participantsNCT06726421
What this trial is testing

Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Kidney Cancer MetastaticRenal Cell Carcinoma Metastatic
Sun Yat-sen University 252
Testing effectiveness (Phase 2)Study completedNCT02855203
What this trial is testing

Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours

Who this might be right for
Renal Cell Carcinoma
Peter MacCallum Cancer Centre, Australia 30
Not applicableStudy completedNCT02956798
What this trial is testing

SAbR For Oligometastatic Renal Cell Carcinoma

Who this might be right for
Oligometastatic Renal Cell Carcinoma
University of Texas Southwestern Medical Center 23
Not applicableLooking for participantsNCT04498767
What this trial is testing

Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

Who this might be right for
Gynecologic CancerSkin CancerHead and Neck Cancer+12 more
European Organisation for Research and Treatment of Cancer - EORTC 200
Not applicableActive Not RecruitingNCT03185039
What this trial is testing

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

Who this might be right for
Kidney Cancer
Institut Paoli-Calmettes 50
Large-scale testing (Phase 3)Looking for participantsNCT06467097
What this trial is testing

Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasm
Samsung Medical Center 88
Not applicableNot Yet RecruitingNCT06585878
What this trial is testing

A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaRCCKidney Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Early research (Phase 1)UnknownNCT05259319
What this trial is testing

Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)

Who this might be right for
Metastatic Non Small Cell Lung CancerMetastatic Bladder CancerMetastatic Renal Cell Carcinoma+1 more
Centre Georges Francois Leclerc 92